| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 753-759, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
U Wagner, L Bubendorf, TC Gasser, H Moch, JP Gorog, J Richter, MJ Mihatsch, FM Waldman and G Sauter
Institute of Pathology, University of Basel, Switzerland.
Alterations of chromosome 8, including deletions of 8p, occur frequently in many tumors. In this study, fluorescence in situ hybridization was used to study the relationship between 8p deletions, 8q gains, and phenotype in bladder cancer. Cells from 87 tumors were examined by dual-labeling fluorescence in situ hybridization with a centromere 8 probe (pJM12) and P1 probes for 8p22, 8p12, 8q12, and 8q24. Both 8p22 deletions and 8q24 gains were strongly associated with tumor phenotype. There was a marked difference in 8p22 deletions between noninvasive (pTa) tumors (3/33) and minimally invasive (pT1) tumors (8/19; P = 0.005) whereas there was no significant difference between pT1 and muscle-invasive (pT2-4) tumors (19/35; P = 0.3926). Six tumors with 8p22 deletion were examined at 8p12. Three of these tumors showed no 8p12 deletion, narrowing down the site of a putative tumor suppressor gene distal to 8p12. In one other case, there was a marked increase in 8p12 copy number (> 40 per cell; amplification), suggesting the presence of an oncogene involved in bladder cancer at 8p12. The marked difference in 8p22 deletions between noninvasive (pTa) and minimally invasive (pT1) tumors is consistent with a role of a putative tumor suppressor gene on 8p for development of invasive tumor phenotype.
This article has been cited by other articles:
![]() |
R. Baffa, M. Fassan, C. Sevignani, A. Vecchione, H. Ishii, E. Giarnieri, R. V. Iozzo, L. G. Gomella, and C. M. Croce Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis Carcinogenesis, April 1, 2008; 29(4): 846 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abubaker, Z. Jehan, P. Bavi, M. Sultana, S. Al-Harbi, M. Ibrahim, A. Al-Nuaim, M. Ahmed, T. Amin, M. Al-Fehaily, et al. Clinicopathological Analysis of Papillary Thyroid Cancer with PIK3CA Alterations in a Middle Eastern Population J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 611 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Saletta, G. Matullo, M. Manuguerra, S. Arena, A. Bardelli, and P. Vineis Exposure to the Tobacco Smoke Constituent 4-Aminobiphenyl Induces Chromosomal Instability in Human Cancer Cells Cancer Res., August 1, 2007; 67(15): 7088 - 7094. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Walker, P. E. Leone, M. W. Jenner, C. Li, D. Gonzalez, D. C. Johnson, F. M. Ross, F. E. Davies, and G. J. Morgan Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma Blood, September 1, 2006; 108(5): 1733 - 1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zheng, R. Simon, M. Mirlacher, R. Maurer, T. Gasser, T. Forster, P. A. Diener, M. J. Mihatsch, G. Sauter, and P. Schraml TRIO Amplification and Abundant mRNA Expression Is Associated with Invasive Tumor Growth and Rapid Tumor Cell Proliferation in Urinary Bladder Cancer Am. J. Pathol., July 1, 2004; 165(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Veltman, J. Fridlyand, S. Pejavar, A. B. Olshen, J. E. Korkola, S. DeVries, P. Carroll, W.-L. Kuo, D. Pinkel, D. Albertson, et al. Array-based Comparative Genomic Hybridization for Genome-Wide Screening of DNA Copy Number in Bladder Tumors Cancer Res., June 1, 2003; 63(11): 2872 - 2880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Harding, K. C. Arden, J. W. Gildea, J. J. Gildea, E. J. Perlman, C. Viars, and D. Theodorescu Functional Genomic Comparison of Lineage-related Human Bladder Cancer Cell Lines with Differing Tumorigenic and Metastatic Potentials by Spectral Karyotyping, Comparative Genomic Hybridization, and a Novel Method of Positional Expression Profiling Cancer Res., December 1, 2002; 62(23): 6981 - 6989. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vecchione, H. Ishii, G. Baldassarre, P. Bassi, F. Trapasso, H. Alder, F. Pagano, L. G. Gomella, C. M. Croce, and R. Baffa FEZ1/LZTS1 Is Down-Regulated in High-Grade Bladder Cancer, and Its Restoration Suppresses Tumorigenicity in Transitional Cell Carcinoma Cells Am. J. Pathol., April 1, 2002; 160(4): 1345 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishii, A. Vecchione, Y. Murakumo, G. Baldassarre, S. Numata, F. Trapasso, H. Alder, R. Baffa, and C. M. Croce FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis PNAS, August 10, 2001; (2001) 181222898. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Simon, J. Richter, U. Wagner, A. Fijan, J. Bruderer, U. Schmid, D. Ackermann, R. Maurer, G. Alund, H. Knonagel, et al. High-Throughput Tissue Microarray Analysis of 3p25 (RAF1) and 8p12 (FGFR1) Copy Number Alterations in Urinary Bladder Cancer Cancer Res., June 1, 2001; 61(11): 4514 - 4519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Simon, E. Eltze, K.-L. Schäfer, H. Bürger, A. Semjonow, L. Hertle, B. Dockhorn-Dworniczak, H.-J. Terpe, and W. Böcker Cytogenetic Analysis of Multifocal Bladder Cancer Supports a Monoclonal Origin and Intraepithelial Spread of Tumor Cells Cancer Res., January 1, 2001; 61(1): 355 - 362. [Abstract] [Full Text] |
||||
![]() |
Z. H. Arbieva, K. Banerjee, S. Y. Kim, S. L. Edassery, V. S. Maniatis, S. K. Horrigan, and C. A. Westbrook High-Resolution Physical Map and Transcript Identification of a Prostate Cancer Deletion Interval on 8p22 Genome Res., February 1, 2000; 10(2): 244 - 257. [Abstract] [Full Text] |
||||
![]() |
S. Knuutila, Y. Aalto, K. Autio, A.-M. Bjorkqvist, W.'e. El-Rifai, S. Hemmer, T. Huhta, E. Kettunen, S. Kiuru-Kuhlefelt, M. L. Larramendy, et al. DNA Copy Number Losses in Human Neoplasms Am. J. Pathol., September 1, 1999; 155(3): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishii, R. Baffa, S.-I. Numata, Y. Murakumo, S. Rattan, H. Inoue, M. Mori, V. Fidanza, H. Alder, and C. M. Croce The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors PNAS, March 30, 1999; 96(7): 3928 - 3933. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishii, A. Vecchione, Y. Murakumo, G. Baldassarre, S. Numata, F. Trapasso, H. Alder, R. Baffa, and C. M. Croce FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis PNAS, August 28, 2001; 98(18): 10374 - 10379. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |